| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |